WHO-GMP & ISO 9001: 2015 CERTIFIED

Suspension

S.No. Product Name Composition Packing Strength
1 Aceclofenac & Paracetamol Suspension Each 5ml contains: Aceclofenac Paracetamol In a Flavoured SyrupyBase. Approved colour used IP IP 100mg 250mg q.s.
2 Acetaminophen, Dextromethorphan, Guaiphenesin, Phenylephrine HCl, Chlorpheniramine Maleate & Menthol Suspension Each 5ml Contains : Acetaminophen Dextromethorphan Hydrobromide Guaiphenesin Phenylephrine Hydrochloride Chlorpheniramine Maleate Menthol In a flavoured Suspension Base Colour: Sunset Yellow FCF USP BP BP BP BP BP 250mg 10mg 50mg 5mg 2mg 1mg q.s
3 Albendazole & Ivermectin suspension Each 5 ml contains: Albendazole Ivermectin Flavoured syrupybase IP IP 200 mg 1.5 mg
4 Albendazole Oral Suspension IP Each ml Contains: Albendazole In flavoured Syrupybase Approved colour used IP 200 mg q.s.
5 Albendazole Oral Suspension IP Each 5ml contains: Albendazole Excipients Approved colour used IP 200mg q.s.
6 Aluminium , Magnesium & simethicone oral Suspension IP Each 10ml contains : Aluminiumhydroxide Gel Equ. to Dried Aluminium Hydroxide Gel Magnesium Hydroxide Paste Equ. to Magnesium Hydroxide Simethicone In a flavoured Palatable Base Colour :Erythrosine & Tartrazine IP IP IP 250mg 250mg 50mg q.s
7 Aluminium Hydroxide, Magnesium Hydroxide & Oxetacaine Oral Suspension Each 5 ml contains: Aluminium Hydroxide (Added Aluminium Hydroxide paste Eq. to dried aluminium hydroxide gel ) Magnesium Hydroxide (Added as magnesium Hydroxide Paste) Oxetacaine Flavoured palatable base IP IP IP BP 0.291 g 0.380 g 98 mg 10 mg q.s.
8 Azithromycin Oral Suspension IP Each 5 ml contains Azithromycin Dihydrate eq. toAnhydrousAzithromycin In a flavoured Syrupybase. Approved Colour Used IP 200mg q.s.
9 Azithromycin Suspension IP Each 5 ml contain: Azithromycin Dihydrate Equivalent to Azithromycin Anhydrous In flavoured Syrupybase Approved colour used IP 100 mg q.s
10 Calcitriol & Calcium Citrate Suspension Each 5ml contains: Calcitriol Calcium Citrate Equ. To Elemental CalciumIn a Flavoured syrupyBase.Approved colour used. IP USP 0.0625mcg 100mg q.s.
11 Calcium Carbonate, & Vitamin D3 Suspension Each 5ml Contains : Calcium Carbonate 625mg (Derived from Oyster Shell) Equ. to elemental Calcium Vitamin D3 Flavoured SyrupyBase ApprovedColour Used IP IP 250mg 125IU q.s.
12 Calcium Carbonate, Magnesium Hydroxide, Zinc & Vitamin D3 Suspension Each 5ml contains: Calcium Carbonate Eq. toElementalCalcium Magnesium Hydroxide Eq. toElemental Magnesium Zinc Gluconate Eq. toElemental zinc Vitamin D3 In a Flavoured syrupybase Approved colour used IP IP USP IP 625 mg 250 mg 180 mg 75 mg 14 mg 2 mg 200 IU
13 Calcium Carbonate, Vitamin d3 Magnesium& Zinc Suspension. Each 5ml contains: Calciumcarbonate (eq. toElemental calcium150mg) Vitamin D3 Magnesium Hydroxide (Eq.to Elemental magnesium) Zinc Gluconate Eq.to Elemental zinc In flavored syrupybase ApprovedColour Used IP IP IP IP 375mg 200IU 25mg 10.45mg 1.5mg q.s.
14 Calcium Phosphorus, Magnesium, Zinc& Vitamin D3 Suspension Each 10ml (2Teaspoonful) Contains: Calcium Phosphate Equ. To Elemental Calcium Equ. ToElemental PhosphorusMagnesium Hydroxide Equ. ToElemental MagnesiumZinc Gluconate Equ. ToElemental ZincVitamin D3 In a Flavoured Palatable Base Approved colour used. IP IP USP IP 300mg 150mg 75mg 4mg 400IU q.s.
15 Calcium, Vitamin D3, Vitamin B12 & Lysine Hydrochloride Suspension Each 5ml contains: Calciumcarbonate Equ. toElemental Calcium Vitamin D3 Vitamin B12 Lysine Hydrochloride Flavoured sorbitol base. Approved colour used. IP IP IP USP 150mg 200IU 2.5mcg 25mg q.s.
16 Deflazacort Oral Suspension Each 5ml contain: Deflazacort In flavoured Syrupybase Approved colour used 6 mg q.s.
17 Dicyclomine Hydrochloride & Simethicone Suspension Each 5ml contains: Dicyclomine Hydrochloride Simethicone Emulsion USP Eq. to Simethicone In a flavoured syrupy base Approved colour used. IP USP 10mg 40mg q.s.
18 Dried Aluminium Hydroxide , Magnesium Hydroxide, Simethicone & Sorbitol Oral Suspension Each 5ml contains : Dried Aluminium Hydroxide Gel Magnesium Hydroxide Activated Simethicone Sorbitol Solution (Non Crystallizing 70%) In a flavoured non syrupy base. Approved colour used IP IP IP IP 250mg 250mg 50mg 1.25gm q.s.
19 Dried Aluminium Hydroxide Gel , Magnesium Hydroxide Gel, Oxetacaine & Activated Dimethicone oral Suspension Each 5ml contains : Dried Aluminium Hydroxide Gel Magnesium Hydroxide Gel Oxetacaine Activated Dimethicone In a Flavoured non syrupybase Approved colour used IP IP IP IP 300mg 250mg 10mg 50mg q.s.
20 Dried Aluminium Hydroxide Gel, Magnesium hydroxide, Oxetacaine and Simethicone Suspension Each 5ml contain: Dried Aluminium Hydroxidegel Magnesium hydroxide Oxetacaine Simethicone In a flavoured sorbitol base Approved colour used IP IP BP IP 600 mg 300mg 10 mg 25 mg q.s.
21 Ferrous Ascorbate & Folic Acid Suspension Each 5ml contains:- Ferrous Ascorbate eq. toElemental Iron Folic Acid Excipients In flavored syrupybase ApprovedColour Used IP 30mg 550mcg q.s.
22 Ferrous Ascorbate, Folic Acid, Methylcobalamin Suspension Each 5ml contains : Methylcobalamin Ferrous Ascorbate Equ. toElemental Iron Folic Acid In a flavoured syrupyBase Approved colour used. IP IP 500mcg 30mg 0.5mg q.s.
23 Ibuprofen & Paracetamol Suspension Each 5ml Contains Ibuprofen Paracetamol Flavoured Palatable base Colour : Sunset Yellow FCF IP IP 100mg 162.5mg q.s
24 Levocarnitine Oral Solution U.S.P. Each 5ml contains: Levocarnitine In a flavoured syrupy base Approved colour used. I.P. 500mg
25 Levocetirizine & Montelukast Suspension Each 5ml Contains : Levocetirizine Hydrochloride Montelukast Sodium Equ. to Montelukast In a flavoured syrupybase. Approved colour used IP IP 2.5mg 4mg q.s.
26 Levocloperastine Fendizoate Oral Suspension Each 5ml Contains : Levocloperastine Fendizoate Equ. To Levocloperastine HClIn a Flavoured Syrupy Base Approved colour used 35.4mg 20mg q.s.
27 Levofloxacin & Ornidazole Oral Suspension Each 5ml Contains : Levofloxacin Hemihydrate Equ. to Levofloxacin Ornidazole In a flavoured SyrupyBase. Approved colour used IP IP 125mg 125mg q.s.
28 Liquid Paraffin & Milk of Magnesia Suspension Each15 ml (tablespoonful 133pprox..)Contains: Liquid Paraffin Milk ofMagnesia flavoured syrupy base Approvedcolour used IP IP 3.75ml 11.25ml q.s.
29 Magaldrate & Simethicone Oral Suspension IP Each 5ml contains : Magaldrate (as anhydrous) Simethicone In a Flavored Syrupybase Approved colour used. IP IP 400mg 60mg q.s
30 Magaldrate, Simethicone & Domperidone Oral Suspension Each 5ml contains: Magaldrate Simethicone Domperidone Sorbitol Solution (70%) (Non-Crystallizing) Approved colour used IP IP IP IP 480mg 20mg 10mg q.s.
31 Magaldrate, Simethicone & Oxetacaine Suspension Each 5ml contains: Magaldrate Simethicone Oxetacaine Excipients Approved colour used IP IP BP 480mg 20mg 10mg q.s.
32 Magaldrate, Simethicone & Oxetacaine Suspension. Each 5ml contains: Magaldrate Simethicone Oxetacaine Excipients Approved colour used. IP IP BP 540mg 50mg 10mg q.s.
33 Magaldrate& Simethicone Oral Suspension Each 5ml contains: Magaldrate Simethicone Sorbitol Solution (70%) (Non Crystallising) In a flavoured sugar freeBase. Approved Colour Used. IP IP 400mg 20mg q.s.
34 Mefenamic Acid & Paracetamol Suspension Each 5mlContains:- Mefenamic Acid Paracetamol In flavoured Palatablebase Approved colour used IP IP 100 mg 250 mg q.s.
35 Mefenamic Acid Oral Suspension Each 5ml contains: Mefenamic Acid In a Flavoured SyrupyBase Approved colour used IP 100mg q.s.
36 Milk of Magnesia, Liquid Paraffin & Sodium Picosulphate Suspension Each 5 ml contain: Milk of Magnesia Liquid Paraffin Sodium Picosulphate Excipients In a Flavoured Sorbitol base Approved colour used IP IP BP 3.75ml 1.25ml 3.33 mg q.s.
37 Milk of Magnesia, Liquid Paraffin and Sodium Picosulfate Suspension Each 5ml contains: Liquid Paraffin Milk of Magnesia Sodium Picosulphate Flavoured Non SyrupyBase Approved colour used IP IP BP 1.25ml 3.75ml 3.33mg q.s.
38 Multivitamin Multimineral & Antioxidant suspension Each 5ml contains: Cholecalciferol (as Stabilized) Pyridoxine HCL Niacinamide Cyanocobalamin Zinc (as Zinc Gluconate ) B-Carotene Dispersion 2.5% Manganese (as Manganese Chloride Tetrahydrate) Molybdenum (as Sodium Molybdate Dihydrate ) Selenium (as Sodium Selenate) Lysine Hydrochloride Iodine(as Potassium Iodide ) Biotin Chromiume (as Chromium Chloride Hexahydrate) Inositol Excipients In a flavoured syrupy base Approved colour used. IP IP IP IP USP USP BP BP IP USP USP USP 200IU 1mg 15mg 1mcg 3mg 38mg 0.8mg 8mcg 10mcg 30mg 50mcg 10mcg 10mcg 10mg q.s.
39 Nitazoxanide for Oral Suspension Composition : Each 5ml of reconstituted suspension contains Nitazoxanide Excipients Approved Colour used 100mg q.s
40 Ofloxacin & Metronidazole Suspension Each 5ml contains : Ofloxacin Metronidazole Benzoate Equ. to Metronidazole In a Flavoured SyrupyBase Colour : Sunset Yellow FCF IP IP 50mg 100mg q.s
41 Ofloxacin & Metronidazole Suspension Each 5ml contains : Ofloxacin Metronidazole Benzoate Equ. to Metronidazole Flavoured Syrupy base Approved colour used. IP IP 50mg 120mg q.s
42 Ofloxacin & Metronidazole Suspension Each 5ml contains : Ofloxacin Metronidazole Benzoate Equ. To Metronidazole In a Flavoured Palatable Base Colour: - Approved colour used. IP IP 100mg 200mg q.s.
43 Ofloxacin oral suspension IP Each 5ml ofsuspension contains Ofloxacin In a flavoured Syrupybase. Approved Colour Used. IP 100mg q.s.
44 Ofloxacin Oral Suspension IP Each 5 ml contains: Ofloxacin Excipients Approved colour used IP 50 mg
45 Ofloxacin, Metronidazole Benzoate & Simethicone Suspension Each 5ml Contains:- Ofloxacin MetronidazoleBenzoate Equivalent toMetronidazole Simethicone In flavoured Syrupybase Approved colour used IP IP IP 50 mg 120mg 10 mg q.s.
46 Paracetamol , Phenylephrine Hydrochloride &Cetirizine Dihydrochloride suspension Each 5ml contains: Paracetamol Phenylephrine Hydrochloride Cetirizine Dihydrochloride In a flavoured base Approved colour used (Banned drug 12/08/2024) IP IP IP 250mg 2.5mg 2.5mg q.s
47 Paracetamol & Domperidone MaleateSuspension Each 5ml contains : Paracetamol Domperidone Maleate Flavoured Palatable Base Colour : Sunset Yellow FCF IP IP 125mg 5mg q.s
48 Paracetamol & Domperidone Suspension Each 5ml contains: Paracetamol Domperidone In a Flavoured syrupyBase Approved colour used IP IP 250mg 5mg q.s.
49 Paracetamol & Mefenamic Acid Suspension Each 5ml Contains Paracetamol Mefenamic Acid In flavoured Palatable base Approved colour used IP IP 125mg 50mg q.s.
50 Paracetamol & Phenylephrine & Chlorpheniramine maleate Suspension Each 5 ml contains :- Paracetamol Phenylephrine HCl Chlorpheniramine maleate In flavoured syrupyBase. Approved Colour Used. IP IP IP IP 250mg 5mg 2mg q.s.
51 Paracetamol Paediatric Oral Suspension IP Each 5ml contains: Paracetamol In a Flavoured SyrupyBase. Approved colour used IP 240mg q.s.
52 Paracetamol Paediatric Oral Suspension IP Each 5ml contains: Paracetamol In a Flavoured SyrupyBase Approved colour used IP 120mg q.s.
53 Paracetamol Suspension IP Each 5ml Contains Paracetamol Excipients Approved colour used IP 125mg q.s.
54 Paracetamol Suspension IP Each 5ml Contains Paracetamol In flavoured Palatablebase Approved colour used IP 250mg q.s.
55 Paracetamol, Chlorpheniramine Maleate & Phenylephrine Hydrochloride Suspension Each 5ml contains Paracetamol Chlorpheniramine Maleate Phenylephrine Hydrochloride Flavoured Palatable Base Approved Colour Used. IP IP IP 125mg 1mg 2.5mg
56 Paracetamol, Dextromethorph nHBr,Cetirizine HCL, ,Phenylephrine HCL, Sodium Citrate & Menthol Suspension Each 5ml Contains: Paracetamol Dextromethorphan HBr Cetirizine HCL Phenylephrine HCL Sodium Citrate Menthol Ina flavoured syrupy base Approved colour use IP IP IP IP IP IP 250mg 5mg 2.5mg 5mg 25mg 1mg q.s
57 Paracetamol, Phenylephrine HCL, & Chlorpheniramine MaleateSuspension Each 5ml Contains:- Paracetamol Phenylephrine HCL Chlorpheniramine Maleate In flavoured Palatablebase Approved colour used IP IP IP 125 mg 5 mg 1 mg q.s.
58 Paracetamol, Phenylephrine HCL, Chlorpheniramine Maleate, Sodium Citrate & Menthol Suspension Each 5ml Contains:- Paracetamol Phenylephrine HCL Chlorpheniramine Maleate Sodium Citrate Menthol In flavoured Syrupybase Approved colour used IP IP IP IP IP 250 mg 5 mg 0.5 mg 60 mg 1 mg q.s.
59 Paracetamol, Phenylephrine HCL, Chlorpheniramine Maleate, Sodium Citrate & Menthol Suspension Each 5ml Contains:- Paracetamol Phenylephrine HCL Chlorpheniramine Maleate Sodium Citrate Menthol In flavoured Syrupybase Approved colour used IP IP IP IP IP 125 mg 5 mg 0.5 mg 60 mg 1 mg q.s.
60 Paracetamol, Phenylephrine Hydrochloride & Cetirizine Dihydrochloride Suspension Each 5ml contains: Paracetamol Phenylephrine Hydrochloride Cetirizine Dihydrochloride In a flavoured Syrupy Base. Approved colour used. (Banned drug 12/08/2024) IP IP IP 125mg 5mg 2mg q.s.
61 Paracetamol, Phenylephrine Hydrochloride & Cetirizine Hydrochloride Suspension Each 5ml contains: Paracetamol Phenylephrine Hydrochloride Cetirizine Hydrochloride In a flavoured SyrupyBase. Approved colour used. (Banned drug 12/08/2024) IP IP IP 125mg 2.5mg 2.5mg q.s.
62 Paracetamol& Dicyclomine Hydrochloride Suspension Each 5ml contains: Paracetamol Dicyclomine Hydrochloride Flavoured Palatable Base Colour: Sunset YellowFCF IP IP 125mg 5mg q.s
63 Posaconazole oral Suspension Each ml contains: Posaconazole Excipients Approved Colour Used IP 40mg q.s
64 Potassium Citrate, Magnesium Citrate & Vitamin B6 Oral Suspension Each 5ml contains : Potassium Citrate Magnesium Citrate Pyridoxine Hydrochloride In a Flavoured SyrupyBase Approved colour used IP USP IP 1100mg 375mg 20mg q.s.
65 Rifaximin & Metronidazole Suspension Each 5 ml contains: Rifaximin Metronidazole Benzoate Eq. to Metronidazole In a flavoured base Excipients Approved colour used. I.P. I.P. 100mg 200mg q.s.
66 Rifaximin Oral Suspension Each 5ml contains: Rifaximin Excipients Approved Colour Used. 100mg q.s.
67 Simethicone, Norfloxacin & Metronidazole Suspension Each 5ml contains : Simethicone Norfloxacin Metronidazole Benzoate Equ. to Metronidazole In a flavoured SyrupyBase Approved colour used IP IP IP 10mg 125mg 125mg q.s.
68 Sodium Alginate, Sodium Bicarbonate & Calcium Carbonate Oral Suspension Each 5 ml contains: Sodium Alginate Sodium Bicarbonate Calcium Carbonate In a flavoured base. Approved colour used IP IP IP 250mg 133.5mg 80mg q.s.
69 Sucralfate & Oxetacaine Oral suspension Each 10ml Contains:- Sucralfate Oxetacaine In palatable sorbitol Base Approved Colour Used. USP BP 1g. 20mg. q.s.
70 Sucralfate & Oxetacaine Suspension Each 5ml contains: Sucralfate Oxetacaine In a flavoured syrupyBase. Approved colour used. USP BP 500mg 10mg q.s.
71 Sucralfate & Oxetacaine Suspension Each 10ml contains: Sucralfate Oxetacaine In a flavoured palatable base Approved colour used IP BP 1g 10 mg q.s.
72 Sucralfate & Oxetacaine Suspension Each 5ml contains: Sucralfate Oxetacaine In a flavoured palatable base Approved colour used USP BP 1g 10 mg q.s.
73 Sucralfateand Oxetacaine Suspension Each 10ml contain: Sucralfate Oxetacaine In a flavoured sorbitol base Approved colour used IP BP IP BP
74 Ursodeoxycholic Oral Acid Suspension Each 5ml Contains : Ursodeoxycholic Acid Excipients Approved colour used IP 250mg q.s.
75 ZincGluconate Suspension Each 5ml contains: Zinc Gluconate Equ. to Elemental Zinc In a flavoured SyrupyBase Colour: Ponceau 4R USP 20mg q.s